Press release
MASH Market Momentum: Late-Stage Assets Fuel Competitive Therapeutic Landscape
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Nonalcoholic Steatohepatitis (NASH), is becoming an increasingly urgent global public health issue. This progressive liver disease, characterized by fat buildup in the liver unrelated to alcohol consumption, can lead to inflammation (hepatitis), fibrosis, cirrhosis, and eventually liver cancer.Download Strategic Sample PDF: https://datamintelligence.com/strategic-insights/sample/metabolic-dysfunction-associated-steatohepatitis-mash?ophp
Akero Therapeutics Completes Enrollment for Double-Blind Phase III SYNCHRONY Real-World Study of Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD - January 2025
Competitive Landscape and Market Positioning
Several major pharmaceutical companies and biotech firms are actively pursuing treatments for MASH:
Leading Late-Stage Pipeline Candidates
Several key players are in advanced clinical development:
• Madrigal Pharmaceuticals - Resmetirom (THR-β Agonist)
• Intercept Pharmaceuticals - Ocaliva (Obeticholic Acid, FXR Agonist)
• Akero Therapeutics - Efruxifermin (FGF21 Analog)
• 89bio - Pegozafermin (FGF21 Analog)
• Novo Nordisk - Semaglutide (GLP-1 Agonist)
• Eli Lilly - Tirzepatide (GLP-1/GIP Agonist)
• Pfizer - PF-06865571 (DGAT2 Inhibitor)
In March 2025- The European Medicines Agency approved AIM-NASH, an AI tool developed using machine learning and trained with extensive pathological data, to assess disease severity in clinical trials.
Get Competitive Intelligence Consultation: https://datamintelligence.com/strategic-insights/ci/metabolic-dysfunction-associated-steatohepatitis-mash?ophp
Several companies are at the forefront of NASH drug development:
✦ Madrigal Pharmaceuticals: Their drug, Rezdiffra, is currently the only approved treatment for MASH in the U.S.
✦ Novo Nordisk: Conducted a late-stage trial of semaglutide, demonstrating significant improvements in liver fibrosis and resolution of steatohepatitis. Regulatory approval is being sought in the U.S. and EU by mid-2025.
✦ Akero Therapeutics: Reported that 39% of patients treated with their drug efruxifermin (EFX) experienced a reversal in cirrhosis symptoms without worsening, compared to 15% in the placebo group.
✦ Viking Therapeutics: Their drug VK2809 showed promising results in Phase IIb trials, with significant improvements in liver fibrosis and a favorable safety profile.
Why Buy Our Pharma Competitive Intelligence Report?
☞ Gain a Competitive Edge
☞ Make Data-Driven Decisions
☞ Benefit from Key Opinion Leader (KOL) Insights
☞ Optimize R&D and Clinical Development
☞ Enhance Market Access & Pricing Strategy
☞ Identify M&A and Licensing Opportunities
☞ Custom-Tailored for Your Needs
Read More: https://datamintelligence.com/strategic-insights/metabolic-dysfunction-associated-steatohepatitis-mash?ophp
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us-
At DataM Intelligence, we help businesses turn competitive insights into breakthrough strategies against targeted therapeutic areas. Born from years of strategic consulting experience, we understand exactly what keeps business leaders up at night. We're not just analysts, we're your strategic partners.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MASH Market Momentum: Late-Stage Assets Fuel Competitive Therapeutic Landscape here
News-ID: 3967580 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Hyperammonemia Market 2025 | Growth Drivers, Trends & Market Forec …
Market Size and Growth
Global Hyperammonemia Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ July 2025: Amogy secured an additional $23 million in venture financing, bringing its total funding to $80 million. This investment aims to accelerate the company's growth and advance its ammonia-to-power solutions.
✅ July 2025: Navigator Gas announced a joint venture with Amon Maritime to construct two ammonia-fueled…

United States Internet of Things (IoT) in Agriculture Market 2025 | Growth Drive …
Market Size and Growth
Global Internet of Things (IoT) in Agriculture Market reached US$ 31.10 billion in 2023 and is expected to reach US$ 83.26 billion by 2031, growing with a CAGR of 13.1% during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States:
✅ In Sep 2025, Sensei Farms (U.S.), backed by Larry Ellison, acquired ~25 acres in Lockhart, Texas - the former facility of robotics-farming company Iron Ox. While…

United States Medical Device Coatings Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
Medical device coatings market is growing at a High CAGR during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States: Recent Medical Device Coatings Developments
✅ In April 2025, the FDA granted 510(k) clearance to Becton Dickinson's CentroVena One central venous catheter, which features an advanced hydrophilic coating to improve device performance.
✅ In March 2025, the U.S. FTC filed suit to block GTCR's planned $627M acquisition of Surmodics…

United States Nephrotic Syndrome Drugs Market 2025 | Growth Drivers, Trends & Ma …
Market Size and Growth
The global nephrotic syndrome drugs market reached US$ 423.7 million in 2023 and is expected to reach US$ 645.3 million by 2030, growing with a CAGR of 5.4% during the forecast period 2024-2031.
Recent Mergers and Acquisitions:
United States:
✅ In June 2025, Biogen initiated a Phase 3 study of felzartamab for the treatment of primary membranous nephropathy, a common cause of nephrotic syndrome. This trial aims to…
More Releases for MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH/NASH) Market Trends, Epid …
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly referred to as Non-Alcoholic Steatohepatitis (NASH), is a progressive form of fatty liver disease characterized by fat accumulation, inflammation, hepatocyte injury, and varying degrees of fibrosis. It is closely linked to obesity, type 2 diabetes, metabolic syndrome, and cardiovascular risk factors.
MASH/NASH is a major global health burden, with prevalence rising due to the global obesity epidemic and sedentary lifestyles. If untreated, it can progress to…
Pepper Mash Market Size Estimated to grow USD 0.517 Billion by 2032
Pepper Mash Market Overview
The pepper mash market is a dynamic segment of the global food industry, characterized by its rich flavor profiles and wide-ranging applications. Pepper mash, a key ingredient in the production of hot sauces, seasonings, and processed foods, has gained significant traction due to its ability to impart heat and complexity to various dishes. This blog delves into the market overview, competitive landscape, key drivers, segmentation, and regional…
Fermented Pepper Mash Market Revenue, Insights, Overview, Outlook, Analysis | Va …
Fermented Pepper Mash Market
Fermented Pepper Mash is one of the most commonly used ingredients in kitchens and hot sauce manufacturers. This product is ideal for making medium-heat hot sauces and marinades. One can add small amounts to stews, soups and pastes to give them a mild flavor. Additionally, people can create their own homemade sauce by adding garlic, onions, vinegar, sugar, lemon juice, and more ingredients.
According to new survey, global…
Pepper Mash Market Production, Consumption, Export-Import Analysis Through 2030
** Market Overview **
Pepper mash refers to a mixture of ground black peppercorns in brine, vinegar or other solutions that is used to impart flavor, spice and heat to various food products. It is used in sauces, marinades, snacks, meat products and other culinary applications across the world.
The growth of the global pepper mash market is being driven by rising demand for convenience foods, growing adoption of international cuisines and…
Mash Tun Media: New UK Marketing Agency working exclusively with breweries
Mash Tun Media, the latest and most focused Digital Marketing Agency for Microbreweries has been developed and launched by the team at Future State Media.
Developing niche-specific skills and understanding of the unique demands of the microbrewing market has been a passion of the team at Future State Media for the past year. Working in the brewing niche has aligned so well with existing successful projects where the team had…
WeFi Launches Twitter Mash-Up
Users of the popular microblogging network can locate their friends anywhere in the world in real time, through the WeFi network of open Wi-Fi hotspots
Delaware, USA, June 2, 2008: WeFi Inc. (wefi.com), creator of the first open, community-based global Wi-Fi network, announced today the launch of their mash-up for Twitter, the popular microblogging network. Twitter users who sign up with WeFi can automatically receive Twitter…